Serum Leptin Levels In Hiv-1 Infected Nigerians Receiving Highly Active Antiretroviral Therapy
The Internet Journal of Endocrinology · 2010
DOI: 10.5580/1a80 ↗At a glance
Journal article in The Internet Journal of Endocrinology, 2010.
Abstract (original language)
INTRODUCTION: The possible effects of highly active antiretroviral therapy (HAART) on serum leptin levels were determined by comparing serum leptin levels in HAART naive and HAART experienced normal weight HIV infected patients.METHODS: A cross sectional study was undertaken in Ahmadu Bello University Teaching Hospital Zaria, Nigeria in 2008. Serum leptin levels by ELISA were determined in 4 groups of individuals including 10 asymptomatic HAART naive HIV-1 positive patients, 10 symptomatic HAART naive HIV-1 positive patients, 20 asymptomatic patients on HAART and 26 healthy HIV negative controls. All groups were normal weight adults matched for age and gender. No patient had HIV associated lipodystrophy or abdominal obesity. RESULTS: Median leptin levels (and ranges) of asymptomatic patients (45.7ng/ml, 25-60), HAART experienced patients (40.6ng/ml, 7.5-90) and healthy controls (50.2ng/ml, 6.3-110) were not statistically different (P>0.05). However, median leptin levels were significantly lower in symptomatic HAART naive patients (29.9ng/ml (2.8-62.5) when compared to other groups (P
Cite
APA
(2010). Serum Leptin Levels In Hiv-1 Infected Nigerians Receiving Highly Active Antiretroviral Therapy. The Internet Journal of Endocrinology. https://doi.org/10.5580/1a80
Vancouver
Serum Leptin Levels In Hiv-1 Infected Nigerians Receiving Highly Active Antiretroviral Therapy. The Internet Journal of Endocrinology. 2010. doi:10.5580/1a80
BibTeX
@article{euvimed2010,
title = {Serum Leptin Levels In Hiv-1 Infected Nigerians Receiving Highly Active Antiretroviral Therapy},
journal = {The Internet Journal of Endocrinology},
year = {2010},
doi = {10.5580/1a80}
}
EUVIMED